Back to search

Article

Single cell RNA-seq discovery of blood biomarkers predicting treatment outcome in severe asthma patients

2025-04-17

Abstract excerpt

Biologic monoclonal antibody therapies for severe asthma target the Type 2 endotype through blockade of the IgE, IL-5/eosinophil, or IL-4/13 pathways, which represents at least two-thirds of patients, and have led to significant clinical benefits in severe asthma management. However, studies show that 10-20% of patients may be non-responders and require a change in therapy. There is also the emerging concept that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98bc4e46-1273-5c17-b26d-4dfb6f252140
DOI
10.1101/2025.04.16.25325934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single cell RNA-seq discovery of blood biomarkers predicting treatment outcome in severe asthma patientsDOI 10.1101/2025.04.16.25325934
Select a neighboring publication to make it the new centre.